<DOC>
	<DOCNO>NCT00123578</DOCNO>
	<brief_summary>Gamma hydroxybutyrate ( GHB ) powerful central nervous system depressant . The number individual seek treatment GHB abuse steadily increase United States . Currently , lorazepam pentobarbital two medication use treat individual experience GHB-withdrawal symptom . The purpose study describe sign symptom GHB withdrawal identify predictor withdrawal severity . The study also evaluate safety effectiveness treatment lorazepam versus pentobarbital GHB detoxification .</brief_summary>
	<brief_title>GHB Withdrawal Symptoms Effectiveness Treatment With Lorazepam Versus Pentobarbital - 1</brief_title>
	<detailed_description>GHB GHB precursor 1,4-butanediol gamma-butylrolactone ( GBL ) become popular drug abuse . In case severe withdrawal , delirium , confusion , hallucination , agitation occur . There sharp rise number GHB related emergency room visit past year , yet little known effective treatment GHB withdrawal dependence . The purpose study describe sign symptom GHB withdrawal , identify predictor withdrawal severity , evaluate safety effectiveness treatment GHB detoxification . There compensation screen assessment . The study include two phase . The open-label Phase 1 aim determine safety lorazepam treatment mild GHB withdrawal . Participants progress moderate severe withdrawal enter control Phase 2 . In Phase 2 , participant randomly assign receive either lorazepam pentobarbital order determine drug effective treating GHB withdrawal . The study consist 1 2 outpatient screen visit , follow 15 day inpatient detoxification treatment assessment . After hospital discharge inpatient treatment , measure protract GHB withdrawal psychiatric symptom obtain outpatient weekly basis 8 week . Repeat measure cognitive functioning obtain baseline , termination treatment , 30 , 60 , 90-day follow-up interval order ass long-term neurocognitive effect GHB withdrawal use .</detailed_description>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Lorazepam</mesh_term>
	<mesh_term>Pentobarbital</mesh_term>
	<criteria>Meets DSMIV criterion GHB dependence Selfreported GHB dependent current daily use GHB Use GHB least 20 consecutive day prior enrollment Desire stop GHB use Availability friend family member act collateral informant Speaks understand English Females pregnant , breastfeeding , agree use adequate form contraception History seizures A baseline EEG clinical concern require inpatient ICU detoxification Any anticonvulsant therapy 3 year prior enrollment Pancreatic disease , insulindependent diabetes Liver disease require medication medical treatment Gastrointestinal kidney disease might significantly impair absorption , metabolism , excretion study drug , might require medication medical treatment Asthma , hive , angioedema , similar condition Acute intermittent porphyria porphyria variegata Neurological psychiatric disorder , include psychosis , bipolar disorder , disorder require treatment might make study compliance difficult ( assess Structured Clinical Interview DSMIVTR ) Positive tuberculosis ( PPD ) skin test clinical history chest Xray indicative active tuberculosis ( individual positive PPD test negative chest Xray , symptomatic tuberculosis require antituberculosis therapy , eligible participate ) Clinically significant abnormal baseline EKG Requirement follow medication currently within 4 week prior enrollment : psychotropics ( include sedatives/hypnotics , antidepressant , neuroleptic ) , prescription analgesic , anticonvulsant , antihypertensive , antiarrhythmic , antiretroviral medication Nicotine dependent participant give nicotine patch therapy duration study ; participant refuse nicotine patch therapy continue study determine hospital smoke standard care regulation Meets DSMIV criterion dependence psychoactive substance GHB , caffeine , nicotine Symptomatic HIV infection Alcohol breath test great .05 ppm time hospital admission</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>